Effect of normobaric oxygen treatment on oxidative stress and enzyme activities in guinea pig heart.
Normobaric oxygen (NBO) therapy is commonly applied for the treatment of various diseases, including myocardial infarctions, but its effectiveness is controversial. Potential adverse effects of hyperoxia are related to excessive formation of free radicals. In the present study we examined the effect of 60-h NBO treatment on lipid peroxidation (LPO), activity of manganese superoxide dismutase (Mn-SOD) and mitochondrial enzymes of energy metabolism in guinea pig heart. NBO treatment resulted in significant accumulation of thiobarbituric acid reactive substances and loss of Mn-SOD activity despite slight elevation of Mn-SOD protein content. Activity of electron transport chain complex III decreased significantly, while activity of complex IV was slightly elevated and citrate synthase was unchanged. LPO, inhibition of Mn-SOD and complex III activities were more pronounced when inhaled oxygen was partially enriched with superoxide radical. In contrast, when O(2) was enriched with oxygen cation (O(2)●+), LPO and loss of Mn-SOD activity were prevented. Complex III activity in the O(2)●+-treated group remained depressed but activities of complex IV and citrate synthase were elevated. These data suggest that NBO treatment is associated with myocardial oxidative damage and attenuation of antioxidant defense, but these adverse effects can be partially attenuated by inhalation of O(2) enriched with oxygen cation.
Department of Medical Biochemistry, Jessenius Faculty of Medicine, Comenius University, Martin, Slovak Republic.
Zuzana
Z
Tatarkova
Ivan
I
Engler
Andrea
A
Calkovska
Daniela
D
Mokra
Anna
A
Drgova
Stanislav
S
Kuka
Peter
P
Racay
Jan
J
Lehotsky
Dusan
D
Dobrota
Peter
P
Kaplan
D000280:Administration, Inhalation; D000818:Animals; D004789:Enzyme Activation / Q000187:drug effects; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D008297:Male; D009206:Myocardium / Q000201:enzymology*; D018384:Oxidative Stress / Q000187:drug effects* / Q000502:physiology*; D010100:Oxygen / Q000008:administration & dosage*; D010102:Oxygen Inhalation Therapy; D013482:Superoxide Dismutase / Q000378:metabolism*
D013482:Superoxide Dismutase; D010100:Oxygen